Complete Up To Date Information about Dexium™.
ANADA Number: 200-312 | |
| Proprietary Name |
Dexium™ |
|---|---|
| Sponsor |
Cross Vetpharm Group Ltd. |
| Sponsor Address |
Broomhill rd. Tallaght, Dublin, 24 IRELAND |
| Ingredients |
Dexamethasone |
| Species |
Cat, no use class stated or implied Horse, no use class stated or implied Dog, no use class stated or implied Cattle, no use class stated or implied |
| Routes of Administration |
Intravenous Intramuscular |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
|
Dosage Amount, Indications & Limitations |
522.540 Dexamethasone injection. Specifications: The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone. Conditions of use: Dogs Amount: 0.25 to 1 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary. Indications: The drug is indicated as an anti-inflammatory agent in dogs. Limitations: Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Cats Amount: 0.125 to 0.5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary. Indications: The drug is indicated as an anti-inflammatory agent in cats. Limitations: Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Cattle Amount: 5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary. Indications: The drug is indicated as an anti-inflammatory agent in cattle. Limitations: Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Horses Amount: 2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary. Indications: The drug is indicated as an anti-inflammatory agent in horses. Limitations: Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food. NAS/NRC status: These conditions are NAS/NRC-reviewed and deemed effective. Applications for these uses need not include effectiveness data as specified by 514.111 of this chapter, but may require bioequivalency and safety information. |